Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study

被引:36
作者
Roux, Perrine [1 ,2 ,3 ]
Le Gall, Jean-Marie [4 ]
Debrus, Marie [5 ]
Protopopescu, Camelia [1 ,2 ,3 ]
Ndiaye, Khadim [1 ,2 ,3 ]
Demoulin, Baptiste [1 ,2 ,3 ]
Lions, Caroline [1 ,2 ,3 ]
Haas, Aurelie [4 ]
Mora, Marion [1 ,2 ,3 ]
Spire, Bruno [1 ,2 ,3 ,4 ]
Suzan-Monti, Marie [1 ,2 ,3 ,4 ]
Carrieri, Maria Patrizia [1 ,2 ,3 ]
机构
[1] INSERM U912 SESSTIM, Marseille, France
[2] Aix Marseille Univ, Marseille, France
[3] ORS PACAObserv Reg Sante Provence Alpes Cote Azur, Grenoble, France
[4] AIDES, Marseille, France
[5] Med Moncle, Paris, France
关键词
Education; HCV; HIV; injecting drug user; intervention; local complications; GENDER-DIFFERENCES; USERS; BEHAVIORS; TRANSMISSION; VANCOUVER; PROGRAMS; FACILITY; COHORT; COMPLICATIONS; EPIDEMIOLOGY;
D O I
10.1111/add.13089
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
AimsTo study the effectiveness of an educational intervention on risks associated with drug injection, comparing primary [unsafe HIV-hepatitis C virus (HCV) practices] and secondary (local complications at injecting site) end-points in harm reduction (HR) programmes offering this intervention versus HR programmes not offering it. DesignThis non-random clustered intervention study was conducted in nine intervention groups (programmes offering the intervention) and eight control groups (programmes not offering it). Each participant was followed-up through a telephone interview at enrolment and at 6 and 12 months. SettingThe study took place in 17 cities throughout France. ParticipantsOf the 271 participants, 144 were enrolled into the intervention group and 127 in the control group. Of the latter, 113 received at least one educational session. InterventionA series of participant-centred face-to-face educational sessions. Each session included direct observation by trained non-governmental organization (NGO) staff or volunteers of participants' self-injecting the psychoactive product they used habitually; analysis by the trained NGO staff or volunteers of the participant's injecting practices, identification of injection-related risks and explanation of safer injecting practices; and an educational exchange on the individual participant's injection practices and the questions he or she asked. MeasurementsPrimary and secondary outcomes were at least one unsafe HIV-HCV practice' and at least one injection-related complication (derived from a checklist). FindingsThe proportion of participants with at least one unsafe HIV-HCV practice in the intervention group decreased significantly, from 44% at M0 to 25% at M6, as well as complications at the injection site (from 66 to 39% at M12), while in the control group it remained mainly stable. Multivariate probit analyses showed that the intervention group experienced a significant reduction in unsafe HIV-HCV practices at M6 [coefficient, 95% confidence interval (CI)=-0.73 (-1.47 to 0.01)] and in injection-related complications at M12 [coefficient, 95% CI=-1.01 (-1.77 to -0.24)], compared with the control group. ConclusionsAn inexpensive and easily implemented educational intervention on risks associated with drug injection reduces significantly unsafe HIV-HCV transmission practices and injection-related complications.
引用
收藏
页码:94 / 106
页数:13
相关论文
共 46 条
  • [1] Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia
    Abel-Ollo, K.
    Rahu, M.
    Rajaleid, K.
    Talu, A.
    Rueuetel, K.
    Platt, L.
    Bobrova, N.
    Rhodes, T.
    Uuskuela, A.
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2009, 21 (07): : 851 - 857
  • [2] Epidemiology of hepatitis C virus infection
    Alter, Miriam J.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (17) : 2436 - 2441
  • [3] Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis
    Aspinall, Esther J.
    Nambiar, Dhanya
    Goldberg, David J.
    Hickman, Matthew
    Weir, Amanda
    Van Velzen, Eva
    Palmateer, Norah
    Doyle, Joseph S.
    Hellard, Margaret E.
    Hutchinson, Sharon J.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2014, 43 (01) : 235 - 248
  • [4] Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program
    Blome, M. Alanko
    Bjorkman, P.
    Flamholc, L.
    Jacobsson, H.
    Molnegren, V.
    Widell, A.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2011, 18 (12) : 831 - 839
  • [5] Carrieri M. P., 2010, 5 C FRANC VIH SIDA C
  • [6] Factors associated with nonadherence to highly active antiretroviral therapy -: A 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase
    Carrieri, MP
    Leport, C
    Protopopescu, C
    Cassuto, JP
    Bouvet, E
    Peyramond, D
    Raffi, F
    Moatti, JP
    Chêne, G
    Spire, B
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (04) : 477 - 485
  • [7] THE MEDICAL COMPLICATIONS OF DRUG-ADDICTION AND THE MEDICAL ASSESSMENT OF THE INTRAVENOUS-DRUG-USER - 25 YEARS LATER
    CHERUBIN, CE
    SAPIRA, JD
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (10) : 1017 - 1028
  • [8] Colón HM, 2001, J ACQ IMMUN DEF SYND, V27, P405, DOI 10.1097/00126334-200108010-00012
  • [9] Self-report among injecting drug users: a review
    Darke, S
    [J]. DRUG AND ALCOHOL DEPENDENCE, 1998, 51 (03) : 253 - 263
  • [10] Rethinking approaches to risk reduction for injection drug users - Differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks
    De, Prithwish
    Cox, Joseph
    Boivin, Jean-Francois
    Platt, Robert W.
    Jolly, Ann M.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (03) : 355 - 361